Malaysian Biotechnology Corporation, Universiti Malaysia Pahang and Evolva collaborate to establish centre of excellence for Malaysian Natural Products
Focus on Biosynthesis of High Value Indigenous Malaysian Natural Products
Evolva Holding SA announced that it will collaborate with Universiti Malaysia Pahang (UMP) to establish a scientific Centre of Excellence for natural products from Malaysia as part of the Flavor and Fragrance Cluster in the state of Pahang.
The Centre of Excellence, which is being facilitated by the Malaysian Biotechnology Corporation (BiotechCorp), under Malaysia’s flagship Bioeconomy Transformation Programme, Bio-Accelerators for Technology Development and Innovation, will focus on the development of natural compounds using Evolva’s yeast fermentation production platform. The goal is to create a new paradigm in the sustainable production of Malaysia’s high value indigenous natural products.
The first programme at the Centre will focus on the production of agarwood fragrances via yeast fermentation. The development of a range of agarwood products by fermentation will allow Malaysia to significantly widen the use of agarwood worldwide, and will complement the existing traditional production approaches.
Agarwood of the Aquilaria and Gyrinops variety has been prized for centuries by incense and perfume makers, and traditional medicine practitioners. More recently, agarwood has been designated as an endangered species by the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES).
Despite conservation measures and concerted efforts to grow Aquilaria and Gyrinops in tree nurseries and organic tree farms, these evergreens are rapidly vanishing from forests due to high demand.
According to data collected by the Wild Trade Monitoring Network, the global supply of wild agarwood could vanish from the planet in less than two years.
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
ADC Therapeutics Licenses Proprietary Antibody from BZL Biologics for Prostate Cancer
